MRNA

Nasdaq

Moderna, Inc.

Health Care, Biotechnology

$59.17

close 7 Aug 2026

+132.31%

52-week change

$23.61B

market cap

$22.28

$85.60

52-week range

Valuation

Market cap$23.61B

P/E (TTM / 5y avg)-7.41x13.62x

Forward P/E (FY2026 / FY2027)——

PEG (TTM / fwd)——

P/S (TTM)10.60x

P/B3.49x

EV/EBITDA (TTM)-7.27x

FCF yield (TTM)-5.27%

Cash flow & dividend

FCF (TTM)-$1.24B

FCF per share (TTM)-$3.12

FCF margin (TTM)-55.83%

Dividend yield (indicated / 5y avg)——

Annualized dividend—

Payout ratio (EPS / FCF)——

Growth & quality

Revenue YoY, latest Q+2.11%

Diluted EPS YoY, latest Q+7.51%

Operating margin (TTM)-149.01%

Net margin (TTM)-141.43%

ROE (latest FY)-32.62%

Net debt / EBITDA (TTM)—

Interest coverage (TTM)-1,106.67

Price

-84.82%-31.50%/yrover 5y

Weekly closes · split-adjusted

close 7 Aug 2026

Fundamentals

Fiscal years, last 10, CAGR chips on growth series, plus a dimmed trailing-twelve-month bar

Revenue

5Y CAGR +19.34%

Diluted EPS

FCF per share

Operating cash flow

Free cash flow

Dividends per share

Payout ratio

Operating margin

FCF margin

Return on equity

Return on capital employed

Shares outstanding

5Y CAGR -0.25%

Interest coverage

Earnings

Street estimates, not SEC filings

Next / Q3 FY26

Date4 Nov 2026bmo

EPS estimate-$1.14

Revenue estimate$931.37M

Last reported

Date—

EPS——

Revenue——